$599

Lilly Initiates Eloralintide Ph3 Program; CKM Guidelines Published; New CagriSema Ph3 Peds Study; Noom Launches GLP-1RA Longevity Program

A series of cardiometabolic-related news items has been observed from Lilly, The Lancet, Novo Nordisk, and Noom. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here